Roche : virtual event on key ophthalmology data presented at the Angiogenesis 2022 Meeting

Investor Update Roche's virtual event on key ophthalmology data presented at the Angiogenesis 2022 Meeting

We are pleased to invite investors and analysts to participate in our virtual event on Monday, 14 February 2022, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2022 Meeting, from 11th to 12th February. 16:30 - 17:45 CET / 15:30 - 16:45 GMT 10:30 - 11:45 am EST / 7:30 - 8:45 am PST The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:00 CET on the day of the event. >click here Access to virtual event (pre-registration required) Please pre-register for our webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to [e-mail]. A replay of the webcast will be available via >ir.roche.com *privacy notice Best regards,
Bruno Eschli Head of Investor Relations	Sabine Borngräber Investor Relations Officer

Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]
Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]	Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]
Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]